ALAMEDA, Calif.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (OTCBB:ACTC), applying proprietary human embryonic stem (ES) cell technology to the emerging field of regenerative medicine, today announced that it has retained Burrill & Company, a specialty merchant bank with expertise in biotechnology and related fields, to act as its financial advisor with regard to the formation of strategic partnerships designed to accelerate development of stem cell based cures and treatments.
